| Line Item | 2022-07-01 | Y/Y |
|---|---|---|
| Revenue | $11.66B | +9.2% |
| Cost of Revenue | $8.19B | +5.5% |
| R&D Expense | $941.0M | +4.2% |
| SG&A Expense | $559.0M | +11.4% |
| Operating Income | $1.96B | +31.0% |
| Interest Expense | $249.0M | +13.2% |
| Pre-tax Income | $1.68B | +24.6% |
| Income Tax | $30.0M | -11.8% |
| Net Income | $1.65B |
| Line Item | 2022-07-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $615.0M | -49.1% |
| Accounts Receivable | $1.53B | +32.3% |
| Inventory | $1.56B | +30.0% |
| Current Assets | $4.03B | +6.7% |
| Total Assets | $8.94B | +3.1% |
| Current Liabilities | $3.56B | +21.7% |
| Long-term Debt | $5.06B | +3.4% |
| Line Item | 2022-07-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.66B | +1.9% |
| Capital Expenditures | $381.0M | -23.5% |
| Investing Cash Flow | -$352.0M | +24.5% |
| Financing Cash Flow | -$1.90B | -13.5% |
| Free Cash Flow | $1.28B | +13.1% |
| +25.5% |
| EPS (Basic) | $7.50 | +38.1% |
| EPS (Diluted) | $7.36 | +37.3% |
| Total Liabilities |
| $8.84B |
| +9.8% |
| Stockholders' Equity | $109.0M | -82.7% |